Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe revision/version indicator on the page was updated from v3.6.0 to v3.6.2, reflecting a minor backend/system update.SummaryDifference0.4%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedNew navigation options 'Check who can join' and 'Find Contact Information' were added to the page, and the revision label was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check28 days agoChange DetectedA new revision entry (v3.5.5) was added, superseding v3.5.4 on the page history. This reflects a software update to the page's revision-tracking system rather than a modification to the trial data.SummaryDifference0.1%

- Check49 days agoChange DetectedThe history page now displays Revision: v3.5.4, replacing the former v3.5.3 and signaling a new UI/software revision for the page.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry v3.5.3 was added to the Record History. The previous revision v3.5.2 was removed from the list to reflect the latest changes to the study record.SummaryDifference0.1%

- Check78 days agoChange DetectedVersion 44 adds Contacts/Locations, Study Design, and Study Status and updates the revision to v3.5.2; the previous revision v3.5.0 was removed on 2025-11-13.SummaryDifference0.4%

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.